1. Lai JI, Hung CC, Lin CY, Chung CL, Li WP, Lin CH, Yu CP, Wang MY, Chu SC, et al. 2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management. Journal of Breast Cancer. 2026;29(3):221-236.

2. Lue KH, Chen YH, Chu SC, Lin CB, Chang BS, Chang PY, Liu SH. Combining the prognostic values of entropy-based heterogeneity features from 18F-fluorodeoxyglucose PET and transmission computed tomography using machine learning in patients with lung adenocarcinoma undergoing curative surgery. Nuclear Medicine Communications. 2026;47(4):479-489.

3. Tan SI, Lue KH, Chen YH, Chu SC, Lin CB, Liu SH. Assessing Respiratory Motion Stability of Novel 18F-Fluorodeoxyglucose Positron Emission Tomography-Derived Morphological Features. Diagnostics. 2026;16(7):994.

4. Tseng CS, Chen YH, Ho CC, Su KY, Chu SC, Liu SH. Clinical Value of 18F-FDG PET in Paraneoplastic and Pembrolizumab-Associated Myositis. Diagnostics. 2026;16(4):596.

5. Lue KH, Wang YH, Chen YH, Chu SC, Lin CB, Liu SH. The prognostic value of 18F-FDG PET-derived whole-body feature in patients with lung adenocarcinoma treated with EGFR-targeted therapy. Annals of Nuclear Medicine. 2026;40(2):121-135.

6. Chu TY, Chen PC, Khine AA, Chen YH, Chu SC, Huang HS. Ovulation releases G-CSF to induce peritoneal neutrophil influx and netosis, facilitating peritoneal seeding of high-grade serous carcinoma. Neoplasia. 2025;70:101236.

7. Khine AA, Huang HS, Chen PC, Hsu CS, Chen YH, Chu SC, Chu TY. A Novel Serum-Based Bioassay for Quantification of Cancer-Associated Transformation Activity: A Case-Control and Animal Study. Diagnostics. 2025;15(15):1975.

8. Chu SC, Hsieh CJ, Yang SH, Yang K, Su KY, Huang WH, Li DK, Kao WY, Li SC, Huang SC, Li CC, Kao RH, Wang TF. Risk of ankylosing spondylitis in long-term follow-up of hematopoietic stem cell donors: impact of HLA-B27 status and donation type. International Journal of Hematology. 2025;121(5):684-693.

9. Khine AA, Chen PC, Chen YH, Chu SC, Huang HS, Chu TY. Correction: Epidermal growth factor receptor ligands enriched in follicular fluid exosomes promote oncogenesis of fallopian tube epithelial cells. Cancer Cell International. 2025;25:54.

10. Khine AA, Chen PC, Chen YH, Chu SC, Chen YS, Huang HS, Chu TY. A simple, economical, and high-yield method for polyethylene glycol-based extraction of follicular and serum-derived extracellular vesicles. Tzu Chi Medical Journal. 2025;37(1):49-57.

11. Chen YH, Lue KH, Chu SC, Lin CB, Liu SH. The value of 18F-fluorodeoxyglucose positron emission tomography-based radiomics in non-small cell lung cancer. Tzu Chi Medical Journal. 2025;37(1):17-27.

12. Lin GL, Chang HH, Lin WT, Liou YS, Lai YL, Hsieh MH, Chen PK, Liao CY, Tsai CC, Wang TF, Chu SC, et al. Dachshund Homolog 1: Unveiling Its Potential Role in Megakaryopoiesis and Bacillus anthracis Lethal Toxin-Induced Thrombocytopenia. International Journal of Molecular Sciences. 2024;25(6):3102.

13. Wang KH, Shen HS, Chu SC, Wang TF, Lin CW, Huang WH, Wu YF, Ho CC, Pang CY, Li CC. Effectiveness of Chinese Herbal Medicine as a Complementary Treatment for Neutropenia Prevention and Immunity Modulation During Chemotherapy in Patients With Breast Cancer: Protocol for a Real-World Pragmatic Clinical Trial. JMIR Research Protocols. 2024;13:e55662.

14. Khine AA, Chen PC, Chen YH, Chu SC, Huang HS, Chu TY. Epidermal growth factor receptor ligands enriched in follicular fluid exosomes promote oncogenesis of fallopian tube epithelial cells. Cancer Cell International. 2024;24(1):424.

15. Wu YF, Shen CL, Huang WH, Chu SC, Li CC, Liu CZ, Wang TF. Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies. International Journal of Laboratory Hematology. 2024;46(4):722-730.

16. Chu SC, Hsieh CJ, Li CC, Yang SH, Li SC, Kao WY, Li DK, Wu YF, Kao RH, Yang K, Wang TF. Long-term follow-up of cancer and catastrophic diseases in hematopoietic stem cell donors: a comprehensive matched cohort study. Bone Marrow Transplantation. 2024;59(6):849-857.

17. Wang LY, Hsieh HH, Chu SC, Chang WC, Kuo YT, Wu TY. Oxaliplatin-associated shock in stage III colorectal cancer patients: real-world evidence in Taiwan. Therapeutic Advances in Drug Safety. 2024;15:20420986241266439.

18. Lue KH, Chen YH, Chu SC, Lin CB, Wang TF, Liu SH. Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study. Annals of Nuclear Medicine. 2024;38(8):647-658.

19. Lue KH, Chen YH, Chu SC, Chang BS, Lin CB, Chen YC, Lin HH, Liu SH. A comparison of 18F-FDG PET-based radiomics and deep learning in predicting regional lymph node metastasis in patients with resectable lung adenocarcinoma: A cross-scanner and temporal validation study. Nuclear Medicine Communications. 2023;44(12):1094-1105.

20. Shih MF, Lue KH, Wang TF, Chu SC, Huang CH. Association between the Neutrophil-to-Lymphocyte Ratio and Infection and Survival in Diffuse Large B Cell Lymphoma. In Vivo. 2023;37(2):948-954.

21. Jhan JY, Wang WE, Chu SC, Cheng CH, Chang CH. Case Report: Ribociclib-induced phototoxicity presented as dyschromia with subsequent bullae formation. Frontiers in Oncology. 2023;13:1184738.

22. Wang D, Wang YH, Chu SC. Case Report: Early diagnosis and bevacizumab-based chemotherapy for primary pericardial mesothelioma: a case with occupational asbestos exposure history. Frontiers in Cardiovascular Medicine. 2023;10:1257373.

23. Chen YH, Lue KH, Lin CB, Chen KC, Chan SC, Chu SC, Chang BS, Chen YC. Genomic and Glycolytic Entropy Are Reliable Radiogenomic Heterogeneity Biomarkers for Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2023;24(4):3988.

24. Chen YH, Chen YC, Lue KH, Chu SC, Chang BS, Wang LY, Li MH, Lin CB. Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma. Annals of Nuclear Medicine. 2023;37(2):139-150.

25. Chu TY, Khine AA, Wu NYY, Chen PC, Chu SC, Lee MH, Huang HS. Insulin-like growth factor (IGF) and hepatocyte growth factor (HGF) in follicular fluid cooperatively promote the oncogenesis of high-grade serous carcinoma from fallopian tube epithelial cells: Dissection of the molecular effects. Molecular Carcinogenesis. 2023;62(9):1417-1427.

26. Kern W, Westers TM, Bellos F, Bene MC, Bettelheim P, Brodersen LE, Burbury K, Chu SC, et al. Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group. Cytometry Part B: Clinical Cytometry. 2023;104(1):51-65.

27. Wang LY, Chu SC, Chang IY, Chan KA. Sex-specific incidence of hepatitis B virus flares among Bcr-Abl tyrosine kinase inhibitor users in Taiwan. Pharmacoepidemiology and Drug Safety. 2023;32(12):1368-1377.

28. Chen YH, Lue KH, Chu SC, Chang BS, Lin CB. The combined tumor-nodal glycolytic entropy improves survival stratification in nonsmall cell lung cancer with locoregional disease. Nuclear Medicine Communications. 2023;44(1):100-107.

29. Wu YF, Gu MH, Liu CZ, Huang WH, Chu SC, Wang TF. Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot study. PLoS ONE. 2022;17(11):e0278040.

30. Fu CJ, Chu SC, Huang SY, Ho CP. Ado-Trastuzumab Emtansine Used in HER2-Positive Metastatic Salivary Gland Carcinoma: Basket Trials and Case Report. Taiwan Journal of Clinical Pharmacy. 2022;30(4):293-301.

31. Chu TY, Chu SC, Khine AA, Chen PC, Lee MH, Huang HS. Effect of ovulation IGF and HGF signaling on the oncogenesis of murine epithelial ovarian cancer cell ID8. Experimental Cell Research. 2022;419(2):113323.

32. Lue KH, Chu SC, Wang LY, Chen YC, Li MH, Chang BS, Chan SC, Chen YH, Lin CB, Liu SH. Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma. Annals of Nuclear Medicine. 2022;36(3):256-266.